PMID: 8947337Nov 1, 1996Paper

Mediator release is altered in immunotherapy-treated patients: a 4-year study

Allergy
D DokicC R Baumgarten

Abstract

In recent years, it has been possible to demonstrate mediator release into the nasal secretion after nasal allergen challenge in patients with allergic rhinitis. Using the nasal provocation model, we determined whether the mediator release was altered in immunotherapy-treated patients. Seventeen grass-pollen-allergic patients were examined under controlled, reproducible conditions. Serial challenges with increasing doses of grass pollen produced increasing numbers of clinical symptoms and release of mediators such as kinins, TAME-esterase activity, and histamine. Ten patients received a semidepot perennial grass-pollen extract for 4 years. Seven patients served as controls and did not receive immunotherapy during the observation period. Data from the group of patients receiving immunotherapy over the first year already showed a partially significant decline in the maximal mediator release after nasal allergen challenges compared to the results of pretreated challenges, whereas controls did not show any significant changes. Nasal allergen challenges after termination of 4 years' immunotherapy significantly modified the mediator release compared to pretreatment values (TAME-esterase activity P < 0.05, kinins P < 0.01, and histami...Continue Reading

References

May 1, 1976·The Journal of Clinical Investigation·R EvansR E Rocklin
Jun 1, 1978·The Journal of Allergy and Clinical Immunology·P S Norman, L M Lichtenstein
Jan 1, 1978·Immunological Reviews·O Strannegård, I L Strannegård
Jan 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H OtsukaM Okuda
Jan 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S R DurhamA B Kay
Jul 1, 1991·The Journal of Allergy and Clinical Immunology·M J FurinR M Naclerio
Sep 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G HedlinN F Adkinson
Dec 1, 1985·The Journal of Clinical Investigation·P S CreticosP S Norman
Jul 11, 1985·The New England Journal of Medicine·R M NaclerioL M Lichtenstein
Aug 1, 1989·The Journal of Allergy and Clinical Immunology·P S CreticosP S Norman
Apr 1, 1987·The Journal of Allergy and Clinical Immunology·R TamirR E Rocklin
Jun 1, 1987·The Journal of Allergy and Clinical Immunology·J BousquetF B Michel
Aug 1, 1987·The Journal of Allergy and Clinical Immunology·D F GraftM D Valentine
Jul 1, 1986·The Journal of Allergy and Clinical Immunology·U R MüllerF Skarvil
Nov 1, 1986·The Journal of Allergy and Clinical Immunology·E F JuniperJ Dolovich
Jul 11, 1985·The New England Journal of Medicine·R R Recker
Jul 1, 1985·The Journal of Clinical Investigation·C R BaumgartenD Proud
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·R PattersonM A Shaughnessy
Dec 1, 1985·The Journal of Allergy and Clinical Immunology·D C LeavengoodH S Nelson
Feb 1, 1973·The Journal of Clinical Investigation·L M LichtensteinB M Hill
May 29, 1980·The New England Journal of Medicine·R E RocklinK L Melmon
Nov 1, 1983·The Journal of Clinical Investigation·D ProudL M Lichtenstein
Jan 1, 1984·The Journal of Allergy and Clinical Immunology·P S CreticosN F Adkinson
Jan 1, 1981·International Archives of Allergy and Applied Immunology·E Puttonen, H J Maasch
Jul 1, 1961·The Journal of Allergy·P P VANARSDEL, E MIDDLETON
Jan 1, 1987·Immunology Today·N R Sinclair, A Panoskaltsis

❮ Previous
Next ❯

Citations

Jun 24, 1998·Allergy·M L Kowalski, M Jutel
Jan 27, 2007·The Cochrane Database of Systematic Reviews·M A CalderonS Durham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.